FANHDI 25 IUML (FACTOR VIII) Իսրայել - անգլերեն - Ministry of Health

fanhdi 25 iuml (factor viii)

medici medical ltd, israel - factor viii (human) - powder for solution for injection - factor viii (human) 250 iu - coagulation factor viii - coagulation factor viii - is indicated for the prevention and control of bleeding in patients with moderate or severe factor viii deficiency due to classical hemophilia a .fanhdi is not effective in controlling the bleeding of patients with von willebrond's disease.

FANHDI 50 IUML (FACTOR VIII) Իսրայել - անգլերեն - Ministry of Health

fanhdi 50 iuml (factor viii)

medici medical ltd, israel - factor viii (human) - powder for solution for injection - factor viii (human) 500 iu - coagulation factor viii - coagulation factor viii - is indicated for the prevention and control of bleeding in patients with moderate or severe factor viii deficiency due to classical hemophilia a . fanhdi is not effective in controlling the bleeding of patients with von willebrond's disease.

FANHDI 100 IUML (FACTOR VIII) Իսրայել - անգլերեն - Ministry of Health

fanhdi 100 iuml (factor viii)

medici medical ltd, israel - factor viii (human) - powder for solution for injection - factor viii (human) 1000 iu - coagulation factor viii - coagulation factor viii - is indicated for the prevention and control of bleeding in patients with moderate or severe factor viii deficiency due to classical hemophilia a . fanhdi is not effective in controlling the bleeding of patients with von willebrond's disease.

FANHDI 100 IUML 1500 IU (FACTOR VIII) Իսրայել - անգլերեն - Ministry of Health

fanhdi 100 iuml 1500 iu (factor viii)

medici medical ltd, israel - factor viii (human) - powder for solution for injection - factor viii (human) 1500 iu/dose - factor viii inhibitor bypassing activity - factor viii inhibitor bypassing activity - is indicated for the prevention and control of bleeding in patients with moderate or severe factor viii deficiency due to classical hemophilia a . fanhdi is not effective in controlling the bleeding of patients with von willebrond's disease.

VAXIGRIP Իսրայել - անգլերեն - Ministry of Health

vaxigrip

medici medical ltd, israel - a/michigan/45/2015 (h1n1)pdm09-like virus; a/singapore/infimh-16-0019/2016 (h3n2) - like virus; b/colorado/06/2017- like virus (b/victoria/2/87 lineage); b/phuket/3073/2013 - like virus (b/yamagata/16/88 lineage) - suspension for injection - b/phuket/3073/2013 - like virus (b/yamagata/16/88 lineage) 15 mcg/dose; a/michigan/45/2015 (h1n1)pdm09-like virus 15 mcg/dose; a/singapore/infimh-16-0019/2016 (h3n2) - like virus 15 mcg/dose; b/colorado/06/2017- like virus (b/victoria/2/87 lineage) 15 mcg/dose - influenza, inactivated, whole virus - influenza, inactivated, whole virus - for the prevention of influenza.

TRIPACEL Իսրայել - անգլերեն - Ministry of Health

tripacel

medici medical ltd, israel - diphtheria toxoid; filamentous haemagglutinin (fha); fimbrae tupes 2 + 3 (fim); pertactin; pertussis acellular; tetanus toxoid - suspension for injection - pertussis acellular 10 mcg / 0.5 ml; filamentous haemagglutinin (fha) 5 mcg / 0.5 ml; fimbrae tupes 2 + 3 (fim) 5 mcg / 0.5 ml; pertactin 3 mcg / 0.5 ml; diphtheria toxoid 30 iu / 0.5 ml; tetanus toxoid 40 iu / 0.5 ml - pertussis, purified antigen, combinations with toxoids - pertussis, purified antigen, combinations with toxoids - is indicated for the primary immunization of infants at or above the age of 2 months and as a booster in children up to their 6th birthday against diphtheria, tetanus and pertussis.

ISENTRESS 400 MG TABLETS Իսրայել - անգլերեն - Ministry of Health

isentress 400 mg tablets

merck sharp & dohme (israel - 1996) company ltd, israel - raltegravir as potassium - film coated tablets - raltegravir as potassium 400 mg - raltegravir - raltegravir - isentress is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv-1) infection in adult patients.this indication is based on safety and efficacy data from two double-blind, placebo-controlled trials in treatment-experienced patients and one double-blind, active-controlled trial in treatment-naive patients.

Medical Air Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

medical air

boc gases ireland ltd - oxygen - medicinal gas, compressed - 21 percent volume/volume - medical gases; oxygen

Medical Oxygen/Carbon Dioxide mixtures Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

medical oxygen/carbon dioxide mixtures

boc gases ireland ltd - oxygen; carbon dioxide - medicinal gas, compressed - percent - medical gases; oxygen; carbon dioxide

AIR SYNTHETIC MEDICINAL Իսրայել - անգլերեն - Ministry of Health

air synthetic medicinal

maxima air separation ltd, israel - oxygen - gas - medicinal, compressed - oxygen 21.0 - 22.5 %v/v - oxygen - gas for inhalation